about
Electrophilic affibodies forming covalent bonds to protein targetsDirect and Propagated Effects of Small Molecules on Protein-Protein Interaction NetworksFine-tuning multiprotein complexes using small moleculesNovel and viable acetylcholinesterase target site for developing effective and environmentally safe insecticidesThe pharmacological landscape and therapeutic potential of serine hydrolasesPhotochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-In situ assembly of enzyme inhibitors using extended tetheringBinding of small molecules to an adaptive protein-protein interfaceMinimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase InhibitorsA Fragment-Based Approach to Probing Adenosine Recognition Sites by Using Dynamic Combinatorial ChemistryStructural model of the p14/SF3b155{middle dot}branch duplex complexIn vitro screening and structural characterization of inhibitors of the S100B-p53 interactionTurning a protein kinase on or off from a single allosteric site via disulfide trapping.Stereo- and regioselective azide/alkyne cycloadditions in carbonic anhydrase II via tethering, monitored by crystallography and mass spectrometryDissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein InterfaceUsing a Fragment-Based Approach To Target Protein-Protein InteractionsOrdering a Dynamic Protein Via a Small-Molecule StabilizerElectrophilic Fragment-Based Design of Reversible Covalent Kinase InhibitorsOvercoming the Limitations of Fragment Merging: Rescuing a Strained Merged Fragment Series TargetingMycobacterium tuberculosisCYP121Integrated biophysical approach to fragment screening and validation for fragment-based lead discoveryAllosteric Inhibition of the NS2B-NS3 Protease from Dengue VirusK-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactionsMotif mediated protein-protein interactions as drug targetsNavigating chemical space for biology and medicineTheory of free energy and entropy in noncovalent bindingDirected discovery of bivalent peptide ligands to an SH3 domainProteome-wide covalent ligand discovery in native biological systemsDependence of Effective Molarity on Linker Length for an Intramolecular Protein−Ligand SystemSmall-molecule inhibitors of protein-protein interactions: progressing towards the dreamModeling functional changes to Escherichia coli thymidylate synthase upon single residue replacements: a structure-based approachTargeting Non-Catalytic Cysteine Residues Through Structure-Guided Drug DiscoverySynthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis.Discovery of an allosteric site in the caspasesDisulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor.Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.Novel acetylcholinesterase target site for malaria mosquito control.Genetic selection for peptide inhibitors of angiogenin.Selective and irreversible inhibitors of aphid acetylcholinesterases: steps toward human-safe insecticides.Rational and modular design of potent ligands targeting the RNA that causes myotonic dystrophy 2.Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3.
P2860
Q24651974-587BBAD2-CC94-444F-BF39-05DD8C973A02Q26784027-87ADEE95-5C79-4DA4-A77C-3BFA57EA6667Q26822675-AC01F272-9718-42F7-B949-96ABEE09E7D1Q26825837-B698C6DD-73E2-4994-8643-4A9E8F46A8DBQ26995817-6469BD31-E0D0-4063-93EC-B58121A6A5E2Q27635309-828A0FF1-9548-499E-879B-63E6608EB0ECQ27640418-CC69AFDA-2E5A-4E1D-B393-BEBEFBB4B6B9Q27640488-28BAB9E7-7908-47B8-A157-F2F73E8C3D88Q27649995-D7E9C1A4-2B31-4EA1-A1CC-06D4DFA5E6E0Q27657770-82211A48-990B-47B4-A5E5-6F42003A3D85Q27665723-11A4307C-6670-4156-8584-B29011909CDDQ27666186-774B1768-8E0D-4AE2-9FA5-F5831F5BCACBQ27667313-65885900-F36B-4447-B279-5191E33137DBQ27667470-4B32D282-238A-4021-B1D7-92BE3AC7DD64Q27674729-07EFE5B1-C47F-49E5-B20E-A72CC4AB71A1Q27675981-29AC859C-27AB-4D51-898F-40FF17AC6DD4Q27676154-7EEBED47-B643-4235-BEC3-1018C16CFC2FQ27677115-C3909AB4-CB90-4394-8D1F-3F78FE244852Q27678718-4F80A406-05B1-4214-A396-4610887914EBQ27679154-B04778CE-5ED3-4841-BC94-B71602207289Q27680467-9875FF61-C89C-4B43-B416-7B11363E00D2Q27680654-76B2536A-C3F2-4DD5-8546-313E1B3FB9CFQ28079554-4DE50E47-9843-4F05-963A-34FA6766AFDCQ28298611-80A66766-A4BB-499C-A9F5-AB7F3D30BF4CQ28383645-8E8A0719-224C-48F5-B446-2984741E83D3Q28585304-88E91AAC-C815-4F1A-8855-EAEDFEBE194BQ28829116-C38415E7-E546-4177-818C-794B36ABD921Q29038357-AA1E9EB5-E731-4318-871C-49DFF59EC09BQ29617758-335D10C4-28D2-4FB2-A66D-4AE3A3CF6D52Q30371403-D3EC3EDC-2D37-4406-B45A-77B083BA4D4EQ30390894-CBBDA70B-4C98-48AD-BD35-A66976165FEAQ30725927-98773D60-0E5C-4F47-97FF-5AD99471B5B7Q30831384-6C3334F3-1571-4D15-9F5D-2581C7D38932Q33211921-73730675-552A-40AC-B37C-7ABA6A703292Q33259490-9BAA0753-38EA-4828-9E1A-1E195E72E0FCQ33267317-3AC9F227-BFBB-446D-B14A-1FDE7D63E8E1Q33321756-81FF7530-D66B-4EF0-96AE-5BFB55B152F9Q33405747-62A4D883-95FB-458E-B221-7A648934A436Q33427148-1E66A5B0-C237-424C-94FF-9C965411D95BQ33474085-01B2A688-4088-43E1-8189-AE1D6519577A
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Site-directed ligand discovery
@ast
Site-directed ligand discovery
@en
Site-directed ligand discovery
@nl
type
label
Site-directed ligand discovery
@ast
Site-directed ligand discovery
@en
Site-directed ligand discovery
@nl
prefLabel
Site-directed ligand discovery
@ast
Site-directed ligand discovery
@en
Site-directed ligand discovery
@nl
P2093
P2860
P3181
P356
P1476
Site-directed ligand discovery
@en
P2093
A C Braisted
D A Erlanson
D R Raphael
E M Gordon
R M Stroud
P2860
P304
P3181
P356
10.1073/PNAS.97.17.9367
P407
P577
2000-08-15T00:00:00Z